C15. Therapeutic preclinical application of NO donor (eg DETANONOate) and CDDP in prostate tumor xenograft regression: molecular mechanism of synergy achieved in apoptosis Article (Faculty180)

cited authors

  • Huerta-Yepez, S; Balis, V; Hernandez-Cueto, A; Huerta, S; Mun~oz-Hernandez, O; Vega, M I; Yeung, K; Waterman, B; Baritaki, S; Spandidos, D; others

authors

publication date

  • 2007

published in

start page

  • 23